News for Kyowa Kirin Co., Ltd. (4151.T)

PR NewswireTHOUSAND OAKS, Calif., May 1, 2025 THOUSAND OAKS, Calif., May 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for

**media[609493]**

”“ Phase 1 dose-escalation study to evaluate ziftomenib in combination with imatinib in patients with advanced GIST after imatinib failure ”“ ”“ Combination

PR NewswireTHOUSAND OAKS, Calif., April 25, 2025 Total Investment in the State to Exceed $1.4 Billion, 750 U.S. Jobs THOUSAND OAKS, Calif., April 25, 2025

PR NewswireTHOUSAND OAKS, Calif., April 11, 2025 First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy, for Patients With Pro

SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the ”œCompany”) ( KURA), a clinical-stage biopharmaceutical company committed to realizi

**media[585963]**

PR NewswireLA JOLLA, Calif. and PRINCETON, N.J., April 3, 2025 -Agreement extends one of the world's most enduring alliances for drug discovery- -Landmark

PR NewswireTHOUSAND OAKS, Calif., April 3, 2025 Breakthrough CD19+ B-Cell Targeted Therapy Delivered an 87% Reduction in the Risk of Flares Versus Placebo

**media[582624]**

PR NewswireTHOUSAND OAKS, Calif., March 13, 2025 Patients Reported Improvement in Ability to Conduct Daily Activities with Twice-Yearly Dosing*Late-Breakin

Amgen Inc (AMGN) and Kyowa Kirin Co., Ltd. have released new results from their ROCKET Phase 3 clinical trial program, evaluating rocatinlimab, a T-cell rebalan

**media[560114]**

PR NewswireTHOUSAND OAKS, Calif., March 4, 2025 THOUSAND OAKS, Calif., March 4, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of

**media[556725]**

PR NewswireTHOUSAND OAKS, Calif., March 1, 2025 Significantly Reduced Nasal Congestion, Polyp Size and Nearly Eliminated Need for Surgery Data Published in

”“ KOMET-001 registrational trial in R/R NPM1-mutant AML achieved primary endpoint ”“ ”“ Alignment reached with FDA and EMA on key aspects of the KOMET-017

**media[551505]**

PR NewswirePRINCETON, N.J., Feb. 26, 2025 PRINCETON, N.J., Feb. 26, 2025 /PRNewswire/ -- Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that results of